Literature DB >> 7543006

Drug sensitivity ("suicide") genes for selective cancer chemotherapy.

F L Moolten1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7543006

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


× No keyword cloud information.
  38 in total

Review 1.  Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.

Authors:  V Schmitz; C Qian; J Ruiz; B Sangro; I Melero; G Mazzolini; I Narvaiza; J Prieto
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect.

Authors:  D Zhou; Y Lu; M S Steiner; J T Dalton
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 3.  Prospects for human gene therapy.

Authors:  A Bout
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

4.  Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma.

Authors:  R M Diaz; T Eisen; I R Hart; R G Vile
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 5.  New therapeutic approaches based on gene transfer techniques.

Authors:  H Chong; R G Vile
Journal:  Springer Semin Immunopathol       Date:  1996

6.  An in vitro nucleoside analog screening method for cancer gene therapy.

Authors:  A Evrard; L Vian; C Aubert; J P Cano
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

Review 7.  Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Authors:  R G Vile; H Chong
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 8.  Gene therapy for cancer--in the dock, blown off course or full speed ahead?

Authors:  R C Vile
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 9.  Gene therapy for cancer, the course ahead.

Authors:  R G Vile
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

10.  TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer.

Authors:  Shan-Yu Guo; Qin-Long Gu; Zheng-Gang Zhu; He-Qun Hong; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.